virus
pathogen
agent
caus
potenti
devast
diseas
flu
hepat
poliomyel
acquir
immunodefici
syndrom
aid
sever
acut
respiratori
syndrom
sar
avian
influenza
footandmous
diseas
mani
antivir
drug
studi
base
function
analysi
viral
gene
understand
viru
life
cycl
mcfarland
hill
show
success
vaccin
mice
pig
mutant
prv
thymidin
kinas
qing
ge
also
demonstr
nucleocapsid
sirna
compon
rna
transcriptas
pa
good
antivir
drug
protect
influenza
viru
inhibit
viral
rna
transcript
sirna
addit
acyclovir
best
antivir
agent
nucleotid
analogu
show
antivir
effect
inhibit
dna
replic
howev
commerciallydevelop
antivir
drug
viral
dna
polymeras
viral
revers
transcriptas
neuraminidas
inhibitor
target
one
two
virus
thu
new
strategi
need
prepar
outbreak
caus
new
virus
new
mutant
virus
high
mutat
rate
viral
genom
recombin
event
among
closelyrel
virus
scfv
recombin
antibodi
fragment
commonli
consist
full
variabl
region
immunoglobulin
heavi
chain
coval
link
correspond
variabl
region
immunoglobulin
light
chain
scfv
multipl
benefit
tradit
monoclon
antibodi
due
greatli
reduc
size
eas
genet
manipul
product
antibodi
viral
protein
scfv
bind
human
immunodefici
viru
regulatori
protein
rev
express
intracellularli
potent
inhibit
replic
scfv
immun
cell
addit
scfv
hiv
integras
revers
transcriptas
show
reduc
viral
progeni
viru
infect
cell
retrovir
capsid
protein
use
antivir
target
therebi
extend
number
target
potenti
use
combin
scfvbase
gene
therapi
approach
howev
despit
mani
viru
resist
studi
use
scfv
protein
report
avail
scfv
antivir
effect
broad
spectrum
virus
montandon
et
al
show
antivir
effect
moloney
murin
leukemia
viru
mmulv
dnase
anoth
studi
dnase
digest
dna
form
unmethyl
provir
mmulv
select
exonucleas
induc
type
interferon
ifn
overexpress
cel
cell
inhibit
hiv
replic
nucleas
activ
anoth
case
report
plant
system
use
rnase
isol
yeast
schizosaccharomyc
pomb
challeng
transgen
potato
express
potato
spindl
tuber
viroid
pstvd
result
suppress
pstvd
infect
accumul
without
signific
undesir
effect
plant
antivir
effect
rnase
depend
rnahydrolyz
activ
shown
previous
scfv
protein
nucleas
activ
nonspecif
degrad
vitro
dna
rna
substrat
scfv
origin
mrl
mice
recombin
singl
chain
antibodi
link
vh
vl
linker
peptid
scfv
catalyt
activ
support
hydrolysi
singl
strand
doubl
strand
dna
presenc
without
signific
sequenc
specif
addit
effici
degrad
rna
scfv
presenc
edta
demonstr
scfv
need
dival
metal
ion
rnase
activ
addit
scfv
dnase
rnase
activ
activ
site
vl
vh
chang
histidin
posit
vh
posit
vl
alanin
respect
sitedirect
mutagenesi
mutant
scfv
lose
dnase
activ
retain
rnase
activ
previous
show
scfv
appli
protect
cell
viru
infect
cell
harbor
scfv
show
resist
classic
swine
fever
viru
csfv
rnase
activ
also
previous
found
progeni
transgen
tobacco
plant
acquir
complet
resist
two
singl
strand
ss
dna
geminivirus
four
ssrna
tobamovirus
one
ssrna
cucumoviru
far
chemic
specif
antibodi
viral
protein
mostli
use
antivir
agent
scfv
complet
differ
mechan
antivir
agent
expect
effect
broad
spectrum
viral
infect
establish
vitro
cell
vivo
mous
system
harbor
scfv
gene
antivir
mechan
prv
hsv
dna
virus
dsdna
genom
express
pattern
viral
open
read
frame
orf
identifi
fret
assay
confoc
microscopi
perform
investig
antivir
mechan
shown
experiment
vitro
vivo
system
taken
togeth
data
support
antivir
effect
dna
viru
use
work
caus
nuclear
dnase
activ
inhibit
dna
replic
rna
transcript
rnase
activ
cytoplasm
block
protein
translat
gene
encod
scfv
introduc
hela
cell
test
whether
scfv
express
cell
line
could
protect
dna
viru
prv
infect
dna
code
wildtyp
scfv
protein
sch
inact
dnasemut
scfv
protein
musch
clone
transcript
depend
cytomegaloviru
promot
vector
figur
three
scfv
line
mutat
scfv
musch
select
serial
dilut
media
contain
evalu
scfv
express
level
select
cell
line
quantit
realtim
revers
transcript
polymeras
chain
reaction
rtpcr
flow
cytometr
analysi
immunocytochemistri
accord
quantit
realtim
rtpcr
express
highest
scfv
rna
compar
two
cell
line
time
mutant
scfvtransfect
musch
cell
express
similar
level
scfv
rna
figur
flow
cytometri
data
reveal
mean
hela
cell
line
control
respect
geo
mean
hela
similar
result
shown
quantit
realtim
rtpcr
analysi
figur
confoc
microscopi
demonstr
scfv
protein
musch
target
local
cytosol
nucleu
figur
common
featur
antidna
antibodi
larg
number
positivelycharg
residu
within
complementar
determin
region
cdr
vh
vl
domain
due
antigen
bind
properti
resembl
nuclear
local
signal
nl
attribut
final
accumul
within
nucleu
cell
cellpenetr
peptid
cpp
therefor
scfv
protein
local
cytosol
use
vector
system
target
nucleu
nl
three
scfv
line
one
mutant
scfv
line
challeng
gfp
prv
dsdna
genom
virusinfect
hela
cell
express
gfp
cytoplasm
hsv
infect
prv
infect
result
cytopath
effect
cpe
hela
cell
addit
prv
result
multinuclear
giant
cell
format
prv
cpe
gfp
express
level
four
cell
line
challeng
three
differ
moi
hsv
gfp
observ
fluoresc
microscop
hour
viru
challeng
line
show
lowest
gfp
express
compar
two
line
mutant
line
musch
figur
plaqu
assay
reveal
cell
produc
fewest
number
viral
progeni
moi
moi
plaqu
assay
data
support
gfp
express
result
show
best
antivir
effect
among
three
cell
line
contrast
wildtyp
hela
cell
time
higher
time
higher
viral
progeni
moi
respect
figur
moi
musch
cell
produc
viral
titer
time
higher
similar
wild
type
hela
cell
figur
western
blot
analysi
use
antihsv
dna
polymeras
antibodi
complex
demonstr
less
dna
polymeras
detect
cell
compar
wildtyp
hela
cell
line
hour
viru
challeng
figur
similar
hsv
prv
also
show
similar
antivir
effect
three
scfv
cell
line
one
mutant
cell
line
fortyeight
hour
prv
challeng
fewer
cytopath
effect
assess
multinuclear
giant
cell
format
observ
cell
compar
type
cell
includ
wildtyp
cell
figur
plaqu
assay
also
show
highest
antivir
effect
cell
viral
titer
moi
respect
compar
wildtyp
hela
cell
respect
musch
cell
line
respect
figur
express
level
scfv
cell
similar
figur
antivir
activ
quit
differ
gener
correl
scfv
express
antivir
activ
howev
order
cell
acquir
antivir
activ
scfv
certain
amount
scfv
protein
need
express
thought
might
threshold
acquir
antivir
activ
confer
scfv
express
may
reach
threshold
figur
glycoprotein
gpd
use
western
analysi
count
prv
gpd
protein
found
line
wildtyp
hela
cell
show
strong
signal
figur
even
though
express
level
scfv
cell
significantli
lower
approx
cell
cell
found
equal
resist
infect
moi
figur
suggest
scfv
protein
level
cell
close
maximum
effect
dose
higher
viru
titer
moi
antivir
effect
scfv
shown
dosedepend
manner
much
less
viral
infect
found
cell
vs
pfuml
demonstr
case
prv
infect
studi
figur
cell
shown
resist
viru
infect
cell
moi
result
scfv
express
level
antivir
effect
show
directli
proport
relationship
fret
assay
carri
confirm
scfv
nucleas
activ
respons
antivir
activ
shown
cell
figur
cell
produc
rel
fluoresc
unit
rfu
min
fam
label
dna
substrat
introduc
cell
howev
fluoresc
output
hela
cell
musch
cell
neg
control
reactant
maximum
rfu
less
figur
famlabel
rna
substrat
introduc
cell
musch
cell
fluoresc
level
rfu
hela
cell
neg
control
reactant
show
fluoresc
level
rfu
figur
fret
result
confirm
scfv
dnase
rnase
activ
rnase
activ
observ
musch
cell
figur
therefor
protect
viru
infect
shown
cell
due
scfv
nucleas
activ
viru
genom
quantit
rtpcr
perform
investig
scfv
protect
viru
infect
relat
viru
infect
cycl
amount
viral
dna
rna
isol
cell
grown
without
hsv
dna
polymeras
inhibitor
phosphonoacet
acid
paa
cultur
media
analyz
quantit
realtim
pcr
figur
paa
inhibit
synthesi
hsv
dna
infect
cell
activ
virusspecif
dna
polymeras
vitro
paa
use
investig
antivir
effect
scfv
dnase
activ
immedi
earli
stage
de
novo
viral
dna
replic
chang
viral
dna
content
hela
musch
cell
trace
immedi
earli
hr
viru
challeng
earli
hr
viru
challeng
late
hr
viru
challeng
stage
infect
figur
viral
dna
accumul
cell
reduc
paauntreat
condit
compar
hela
cell
stage
viru
dna
accumul
cell
cultur
paa
decreas
compar
hela
cell
stage
infect
contrast
musch
cell
paauntreat
condit
show
much
viru
dna
accumul
hela
cell
earli
stage
infect
viral
dna
detect
musch
cell
compar
hela
cell
late
stage
accumul
viru
dna
indic
nuclear
scfv
degrad
viral
dna
directli
result
less
accumul
viral
dna
figur
viral
rna
express
also
analyz
experiment
condit
viral
rna
accumul
six
orf
decreas
rapidli
paatreat
cell
earli
late
stage
infect
figur
cell
show
substanti
reduct
viral
rna
accumul
entir
infect
cycl
paauntreat
condit
compar
hela
musch
cell
express
cell
cultur
paa
decreas
respect
compar
hela
cell
immedi
earli
stage
late
infect
stage
cell
express
less
ul
transcript
respect
hela
cell
viru
challeng
figur
howev
level
lower
hela
cell
immedi
earli
stage
musch
cell
infect
similar
viral
rna
content
seen
cell
howev
late
stage
infect
viral
rna
accumul
pattern
musch
cell
similar
hela
cell
figur
rna
transcript
occur
immedi
earli
stage
viral
infect
stage
togeth
limit
level
dna
replic
summar
edward
k
wagner
web
site
http
therefor
absenc
paa
decreas
level
viral
dna
musch
cell
comparison
hela
cell
like
attribut
interfer
hsv
transcript
rnase
activ
mutant
scfv
figur
treatment
paa
specif
inhibitor
viral
dna
polymeras
level
viral
dna
replic
musch
hela
cell
shown
almost
ident
immedi
earli
stage
rel
mild
impact
paa
dna
replic
musch
cell
compar
hela
cell
also
observ
select
viral
rna
transcript
measur
cell
immedi
earli
stage
figur
transcript
gene
found
significantli
decreas
hela
cell
upon
paa
reflect
decreas
level
viral
dna
templat
transcript
contrast
transcript
level
gene
musch
cell
stage
show
signific
differ
paa
treat
untreat
cell
entri
nucleu
genom
also
associ
rapidli
histon
protein
nucleosom
assembl
though
irregularli
randomli
space
manner
hour
post
infect
therefor
intrigu
difficult
explain
viral
genom
subject
nucleic
acid
hydrolyz
activ
scfv
leav
host
genom
larg
unaffect
perhap
genom
complet
assembl
nucleosom
assembl
unstabl
nucleosom
digest
intrins
dnase
scfv
replic
take
place
hour
post
infect
earli
stage
especi
consid
viral
genom
found
rel
free
histon
follow
viral
dna
replic
beyond
hour
post
infect
compar
dna
accumul
musch
cell
immedi
earli
stage
earli
stage
late
stage
respect
musch
cell
show
limit
antivir
activ
immedi
earli
stage
show
antivir
activ
later
thu
may
indic
mutant
scfv
intrins
rnase
activ
suffici
provid
full
protect
host
cell
infect
dna
replic
success
take
place
nucleu
musch
cell
therefor
may
possibl
antivir
effect
scfv
prv
infect
contribut
dnase
activ
mainli
effect
nucleu
rnase
activ
mainli
effect
cytoplasm
propos
antivir
activ
explain
tempor
blockag
viral
dna
replic
nucleu
protein
translat
cytosol
spatial
protect
nucleu
vs
cytosol
provid
scfv
howev
experiment
investig
need
confirm
antivir
mechan
scfv
propos
studi
scfv
protein
shown
local
cytoplasm
nucleu
figur
test
hypothesi
scfv
act
dnase
nucleu
investig
whether
scfv
could
hydrolyz
histonebound
dna
methyl
dna
scfv
dnase
start
hydrolyz
dna
hr
treatment
concentr
scfv
digest
nonmethyl
dna
methyl
dna
hr
treatment
figur
addit
quantit
nonmethyl
methyl
dna
show
reduct
rate
respect
figur
howev
differ
hydrolysi
nonmethyl
methyl
dna
observ
dnase
test
figur
scfv
dnase
digest
dna
concentr
regardless
whether
methyl
figur
next
test
whether
scfv
protein
could
digest
histonebound
dna
nucleu
histonebound
dna
fragment
bp
hydrolyz
either
scfv
dnase
concentr
shown
figur
concentr
scfv
dna
without
histon
reduc
hr
hr
respect
figur
also
scfv
digest
dna
without
histon
dnase
concentr
hr
treatment
figur
nuclear
dna
eukaryot
cell
mostli
modifi
methyl
interact
variou
nuclear
protein
histon
protein
figur
show
scfv
hydrolyz
methyl
histonebound
dna
activ
scfv
result
indic
chromosom
dna
nucleu
protect
scfv
chromosom
dna
mostli
methyl
histonebound
scfv
protein
cell
express
lower
work
concentr
test
vitro
analysi
shown
figur
hela
musch
cell
show
similar
doubl
pattern
hr
growth
curv
plot
figur
northern
blot
analysi
show
rna
stabil
rna
express
pattern
three
marker
gene
gapdh
actin
vegf
three
cell
line
affect
express
scfv
protein
figur
taken
togeth
express
scfv
protein
cell
affect
cell
growth
viabil
rnase
activ
use
antivir
protein
potato
spindl
tuber
viroid
hiv
respect
observ
other
effect
exogen
express
rnase
andor
nucleas
scfv
indic
possibl
develop
transgen
plant
anim
cell
even
entir
organ
virusresist
howev
host
rna
could
degrad
nonselect
scfv
rnase
activ
scfvexpress
cell
transform
process
antivir
transgen
cell
line
organ
develop
amount
scfv
protein
express
inhibit
physiolog
development
process
cell
organ
amount
scfv
protein
produc
suffici
protect
viru
infect
scfv
dnase
transfer
hela
cell
use
micropor
investig
cell
viabil
use
neutral
red
assay
concentr
protein
adjust
unit
cell
viabil
differ
observ
scfv
dnase
scfv
dnase
concentr
unit
figur
scfv
dnase
detect
cytosol
nucleu
hela
cell
confoc
microscopi
figur
montandon
et
al
report
antivir
effect
dnase
mmulv
mous
cell
dnase
digest
nonmethyl
dna
provir
mmulv
hydrolyz
methyl
endogen
mmulv
howev
introduc
unit
amount
dnase
scfv
hela
cell
use
micropor
antivir
effect
scfv
protein
almost
higher
dnase
figur
result
indic
scfv
greater
antivir
effect
dnase
like
due
addit
rnase
activ
scfv
figur
antivir
effect
scfv
protein
confirm
hela
cell
transform
mice
harbor
scfv
gene
produc
investig
antivir
effect
vivo
mous
system
scfv
plasmid
linear
nruistuipvui
enzym
use
transform
total
gener
line
select
pcr
analysi
figur
transform
reconfirm
southern
hybrid
genom
dna
digest
ecori
hindiii
enzym
transform
show
singl
band
react
probe
prepar
scfv
full
gene
figur
scfv
express
level
analyz
differ
transgen
line
differ
organ
muscl
brain
liver
chosen
organ
viru
infect
rout
rel
scfv
gene
express
level
investig
quantit
realtim
rtpcr
figur
line
select
line
analysi
base
scfv
express
level
tg
mice
line
previou
therapeut
experi
show
prv
detect
muscl
brain
mice
challeng
prv
scfv
protein
intramuscular
intraperiton
inject
respect
therefor
line
express
highest
scfv
level
brain
muscl
line
express
high
amount
scfv
brain
select
use
investig
antivir
prevent
effect
line
show
posit
gpcr
rtpcr
result
scfv
express
level
line
low
thu
use
control
basi
express
level
line
line
produc
time
scfv
liver
line
show
time
less
line
howev
line
time
scfv
brain
line
even
time
therefor
line
use
control
line
use
test
antivir
prevent
effect
tg
mice
line
prv
infect
figur
scfv
tg
founder
line
mate
wildtyp
establish
line
produc
sibl
line
four
line
produc
line
four
line
mate
wildtyp
line
produc
use
viru
challeng
experi
name
case
line
three
line
five
line
produc
line
line
prepar
figur
genom
pcr
perform
confirm
transgen
line
gener
data
shown
number
live
dead
mice
count
everi
hr
day
investig
viabil
tg
line
femor
muscl
challeng
prv
figur
figur
show
viabil
wt
mice
challeng
prv
viabil
line
prv
challeng
respect
howev
line
show
viabil
data
describ
analysi
mice
gener
began
exhibit
clinic
sign
ill
day
postchalleng
figur
rtpcr
immunohistochemistri
perform
confirm
viru
accumul
three
scfv
tg
line
prv
inocul
figur
show
prv
gpd
rna
detect
muscl
brain
wt
mice
accompani
diseas
symptom
immunohistochem
analysi
antigpd
antibodi
support
viral
gene
express
data
wt
mice
high
infect
rate
purkinj
layer
cell
brain
stain
dark
brown
diaminobenzidin
dab
stain
figur
data
indic
viru
multipl
inhibit
scfv
protein
viru
infect
protect
earli
infect
stage
scfv
protein
also
indic
prv
dna
hydrolyz
immedi
virusinocul
muscl
cell
viru
titer
high
enough
infect
muscl
cell
therefor
prv
could
move
system
spinal
cord
brain
mice
howev
mice
protect
prv
infect
even
though
scfv
protein
express
brain
figur
similar
level
observ
mice
interpret
data
indic
express
presenc
antivir
protein
inocul
cell
tissu
import
high
express
level
target
cell
tissu
blood
biochemistri
tabl
bodi
weight
chang
week
birth
figur
significantli
differ
wt
mice
also
identifi
express
pattern
endogen
gene
includ
apoptosi
kra
bax
growth
factor
vegf
housekeep
gapdh
gene
wildtyp
mice
howev
differ
figur
although
demonstr
antivir
effect
attribut
dnase
rnase
activ
scfv
without
cytotox
effect
host
cell
studi
figur
possibl
host
dna
damag
nonspecif
nucleas
activ
scfv
entir
rule
previou
studi
test
potenti
cytotox
effect
scfv
hela
cell
vari
concentr
scfv
hr
cell
viabil
found
drop
upon
scfv
treatment
treatment
cell
scfv
exhibit
signific
cytotox
h
incub
respect
may
indic
host
cell
inde
begin
affect
nonspecif
activ
scfv
higher
dosag
ie
although
clear
exactli
much
scfv
protein
actual
penetr
cell
media
scfv
protein
administ
scfv
fairli
larg
amount
protein
vitro
cytotox
analysi
even
though
use
amount
protein
vivo
surviv
experi
mice
figur
hand
actual
level
scfv
express
transgen
cell
cell
line
low
even
detect
western
blot
analysi
although
express
confirm
confoc
microscop
observ
flow
cytometri
analysi
figur
therefor
conclud
low
concentr
scfv
express
transgen
cell
line
tg
mice
gener
suffici
confer
antivir
effect
without
incur
damag
host
dna
likelihood
scfv
deleteri
impact
host
cell
well
nonspecif
nucleic
acid
hydrolyz
activ
remain
valid
especi
higher
concentr
protein
conclus
dna
virusprotect
effect
confer
scfv
protein
attribut
dnase
activ
protein
nucleu
rnase
activ
cytoplasm
antibodi
inhibit
viral
dna
replic
rna
transcript
nucleu
viral
dna
degrad
viral
protein
translat
cytoplasm
via
viral
rna
degrad
word
scfv
protein
attack
viru
dna
genom
rna
transcript
two
differ
subcellular
space
nucleu
cytoplasm
two
differ
time
viral
replic
viral
transcript
figur
antivir
effect
scfv
observ
virus
dsdna
genom
also
ssrna
virus
csfv
sever
plant
virus
geminiviru
tobamoviru
cucumoviru
taken
togeth
scfv
candid
antivir
protein
potenti
confer
resist
broad
spectrum
anim
plant
virus
hela
cell
provid
korean
cell
line
bank
maintain
dmem
medium
supplement
fetal
bovin
serum
hyclon
logan
ut
usa
uml
penicillinstreptomycin
hyclon
nonessenti
amino
acid
sigma
st
loui
mo
usa
atmospher
hsvgfp
viru
obtain
american
type
cultur
collect
atcc
number
prvi
strain
obtain
nation
veterinari
research
quarantin
servic
nvrq
korea
scfv
polyclon
antibodi
provid
dr
kwon
ajou
univers
school
medicin
antiprv
gd
monoclon
antibodi
purchas
jeno
biotech
inc
chuncheon
korea
antihsv
monoclon
antibodi
obtain
chemicon
temecula
ca
usa
antigapdh
polyclon
antibodi
purchas
santa
cruz
biotechnolog
santa
cruz
ca
usa
scfv
scfv
amplifi
pcr
scfv
vector
subclon
vector
invitrogen
carlsbad
ca
usa
scfv
scfv
transfect
hela
cell
use
fugen
hd
transfect
reagent
roch
indianapoli
usa
select
select
rel
concentr
scfv
scfv
calcul
quantit
realtim
pcr
normal
gapdh
gene
tabl
primer
effici
scfv
gapdh
respect
confoc
microscopi
flow
cytometri
perform
describ
previous
cell
coverslip
wash
phosphatebuff
salin
pb
fix
min
paraformaldehyd
pb
room
temperatur
cell
permeabil
permbuff
bsa
saponin
sodium
azid
pb
min
room
temperatur
rt
block
bsa
pb
hr
scfvtreat
cell
incub
rabbit
scfv
ab
follow
tritcantirabbit
ig
nuclei
stain
dapi
last
min
incub
rt
cell
coverslip
mount
vectashield
antifad
mount
medium
vector
lab
burlingam
ca
usa
observ
zeiss
lsm
laser
confoc
microscop
analyz
carl
zeiss
lsm
imag
softwar
jena
germani
scfvtransfect
cell
line
assess
flow
cytometri
hela
cell
grown
sixwel
plate
cellswel
preincub
serumfre
dmem
min
either
untreat
treat
inhibitor
min
scfv
mm
treatment
cell
suspend
trypsin
treat
trypsin
min
wash
surfacebound
protein
wash
icecold
pb
cell
fix
permeabil
per
procedur
describ
cell
wash
icecold
pb
twice
label
antirabbit
scfv
ab
follow
tritcantirabbit
ab
analyz
use
fac
calibur
tm
bd
bioscienc
san
diego
ca
usa
total
cell
analyz
test
quantif
dna
rna
cell
musch
hela
carri
harvest
cell
hour
post
infect
hpi
hpi
hpi
immedi
earli
stage
earli
stage
late
stage
respect
summar
figur
rna
isol
cell
mous
tissu
liver
muscl
lung
brain
use
corezol
reagent
corebio
system
cdna
synthes
total
rna
use
random
hexam
mmlv
revers
transcriptas
superbio
primer
design
use
primer
program
express
level
immedi
earli
gene
transcript
transactiv
regulatori
protein
earli
gene
replic
origin
bind
singlestrand
bind
protein
late
gene
capsid
protein
capsid
assembl
analyz
rotorgen
corbett
research
sydney
australia
tabl
primer
effici
respect
data
point
repres
averag
three
individu
experi
error
bar
indic
standard
error
virusinfect
hela
cell
cell
lyse
use
proprep
intron
daejeon
korea
cell
lysat
analyz
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
transfer
nitrocellulos
membran
use
semidri
method
incub
primari
antibodi
dilut
cleav
caspas
infbeta
dilut
prv
gd
hsv
hr
incub
goat
antimous
rabbit
igghrp
conjug
hr
baselong
ribooligonucleotid
nm
label
fam
terminu
black
hole
quencher
bhq
terminu
synthes
famcgatgagtgccatggatatacbhq
anneal
nonlabel
complementari
ribooligonucleotid
deliv
cell
plate
use
lipofectamin
transfect
reagent
invitrogen
immedi
chang
medium
realtim
fluoresc
intens
cell
read
hr
real
time
use
fluoresc
analyz
min
interv
molecular
devic
sunnyval
ca
usa
vero
cell
cultur
plate
nunc
tenfold
serial
dilut
viru
sampl
prepar
serumfre
dmem
media
dilut
use
infect
vero
cell
duplic
viru
allow
adsorb
hr
hr
incub
vero
cell
rins
twice
pb
stain
crystal
violet
solut
min
plate
wash
viru
titer
calcul
plaqu
analysi
includ
four
biolog
three
technic
replic
cell
line
infect
viru
four
time
number
plaqu
vero
cell
count
three
time
respect
use
cultur
media
contain
virus
hela
genom
methyl
dna
nonmethyl
dna
purchas
neb
dna
type
treat
scfv
dnase
three
differ
unit
concentr
hela
chromatin
prepar
use
ezzym
enzymat
chromatin
prep
kit
upstat
technolog
usa
prepar
chromatin
dna
nake
dna
treat
scfv
dnase
respect
dna
sampl
harvest
hr
incub
dna
sampl
analyz
agaros
gel
abzym
analysi
rel
quantif
dna
measur
height
valu
perform
use
genesnap
softwar
syngen
uk
neutral
red
nr
cytotox
assay
perform
test
cell
viabil
treatment
dnase
scfv
dnase
scfv
concentr
rang
unit
unit
transfer
hela
cell
use
micropor
incyto
uptak
neutral
red
dye
intracellular
acid
compart
determin
measur
absorb
nm
scfv
transgen
mice
produc
macrogen
co
use
standard
microinject
procedur
briefli
fertil
mous
egg
flush
oviduct
superovul
mice
male
pronuclei
inject
kb
fragment
scfv
obtain
digest
b
scfv
vector
nruistuipvui
restrict
enzym
inject
egg
reimplant
oviduct
pseudopregn
recipi
femal
week
age
anim
test
presenc
transgen
pcr
analysi
genom
dna
use
forward
cagagctctctggctaactag
revers
primer
ctgttgaacagactctgactg
tg
founder
line
mate
wildtyp
mice
establish
transgen
line
produc
sibl
line
breed
program
provid
macrogen
co
principl
laboratori
anim
care
nih
public
revis
follow
experi
carri
guidelin
nvrq
korea
southern
blot
hybrid
use
confirm
integr
determin
copi
number
scfv
gene
transgen
mice
genom
dna
transform
digest
ecori
hindiii
restrict
enzym
dna
separ
agaros
gel
scfvspecif
radiolabel
probe
prepar
scfv
vector
three
scfv
tg
mous
line
wildtyp
line
divid
five
group
without
prv
infect
wtmock
wtprv
mice
challeng
prv
intramuscular
inject
surviv
rate
group
calcul
hr
interv
figur
tissu
muscl
brain
harvest
store
rtpcr
immunohistochem
analys
repres
brain
tissu
section
immunohistochem
analysi
mount
silaneco
slide
describ
ramosvara
antiprv
gpd
antibodi
jeno
biotech
inc
use
primari
antibodi
appli
min
rt
sampl
treat
color
develop
dab
detect
kit
ventana
medic
system
germani
blood
collect
wildtyp
mice
centrifug
rpm
min
plasma
store
analysi
plasma
level
total
albumin
aspart
aminotransferas
alanin
transaminas
total
protein
analyz
use
automat
blood
chemistri
analyz
selectra
ii
merck
germani
analys
carri
use
graphpad
prism
program
graphpad
softwar
la
jolla
ca
usa
oneway
analysi
varianc
tukey
post
hoc
ttest
use
statist
analys
data
present
mean
se
p
consid
signific
kaplanmei
surviv
analysi
use
compar
surviv
prv
infect
statist
p
valu
gener
wtprv
logrank
test
